Top MarketRank™ StocksTop MarketRank™NYSE:DGX Quest Diagnostics (DGX) Stock Price, News & Analysis $150.79 -1.34 (-0.88%) (As of 10/4/2024 08:49 PM ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends About Quest Diagnostics Stock (NYSE:DGX) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Key Stats Today's Range$150.42▼$152.4950-Day Range$142.10▼$156.9752-Week Range$120.10▼$159.36Volume500,800 shsAverage Volume929,925 shsMarket Capitalization$16.75 billionP/E Ratio20.29Dividend Yield1.99%Price Target$154.33Consensus RatingHold Company OverviewQuest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.Read More… Notice: Major payout due November 19th - are you on the list? (Ad)On Tuesday, November 19, 2024 smart investors will collect their share of a $1.2 billion windfall... It's part of a unique strategy which has nothing to do with risky investments like options, cryptos or forex. And while it might sound crazy...Click here for the ticker >>> Quest Diagnostics Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks99th Percentile Overall ScoreDGX MarketRank™: Quest Diagnostics scored higher than 99% of companies evaluated by MarketBeat, and ranked 19th out of 997 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.2 / 5Analyst RatingHold Consensus RatingQuest Diagnostics has received a consensus rating of Hold. The company's average rating score is 2.31, and is based on 4 buy ratings, 9 hold ratings, and no sell ratings.Amount of Analyst CoverageQuest Diagnostics has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Quest Diagnostics' stock forecast and price target. Earnings and Valuation2.5 / 5Proj. Earnings Growth7.76% Earnings GrowthEarnings for Quest Diagnostics are expected to grow by 7.76% in the coming year, from $8.89 to $9.58 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Quest Diagnostics is 20.29, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 129.01.Price to Earnings Ratio vs. SectorThe P/E ratio of Quest Diagnostics is 20.29, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 124.33.Price to Earnings Growth RatioQuest Diagnostics has a PEG Ratio of 2.80. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioQuest Diagnostics has a P/B Ratio of 2.67. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Quest Diagnostics' valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.18% of the float of Quest Diagnostics has been sold short.Short Interest Ratio / Days to CoverQuest Diagnostics has a short interest ratio ("days to cover") of 2.9, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Quest Diagnostics has recently decreased by 5.10%, indicating that investor sentiment is improving significantly. Dividend4.2 / 5Dividend StrengthStrong Dividend YieldQuest Diagnostics pays a meaningful dividend of 1.94%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthQuest Diagnostics has been increasing its dividend for 13 years.Dividend CoverageThe dividend payout ratio of Quest Diagnostics is 40.38%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Quest Diagnostics will have a dividend payout ratio of 31.32% next year. This indicates that Quest Diagnostics will be able to sustain or increase its dividend.Read more about Quest Diagnostics' dividend. Sustainability and ESG4.7 / 5Environmental Score-0.62 Percentage of Shares Shorted2.18% of the float of Quest Diagnostics has been sold short.Short Interest Ratio / Days to CoverQuest Diagnostics has a short interest ratio ("days to cover") of 2.9, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Quest Diagnostics has recently decreased by 5.10%, indicating that investor sentiment is improving significantly. News and Social Media2.3 / 5News Sentiment1.21 News SentimentQuest Diagnostics has a news sentiment score of 1.21. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.53 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 8 news articles for Quest Diagnostics this week, compared to 9 articles on an average week.Search InterestOnly 1 people have searched for DGX on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Quest Diagnostics to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Company Ownership2.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Quest Diagnostics insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $365,081.00 in company stock.Percentage Held by InsidersOnly 0.79% of the stock of Quest Diagnostics is held by insiders.Percentage Held by Institutions88.06% of the stock of Quest Diagnostics is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Quest Diagnostics' insider trading history. DGX Stock News HeadlinesBalancing Growth Prospects and Challenges: A Hold Recommendation for Quest DiagnosticsOctober 4 at 5:49 PM | markets.businessinsider.comQuest Diagnostics (NYSE:DGX) Stock, Guidance And ForecastOctober 3, 2024 | benzinga.comKamala’s tax plan is worse than you think—find out whyBuffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track record starts pulling out of the market, it's time to pay attention.October 7, 2024 | Genesis Gold Group (Ad)Quest Diagnostics Enhances Patient-Centered Care With Streamlined Services, Innovative Testing, and a Commitment to Health Equity in 2023October 2, 2024 | stockhouse.comShort Interest in Quest Diagnostics Incorporated (NYSE:DGX) Decreases By 5.1%October 1, 2024 | americanbankingnews.comZacks Research Weighs in on Quest Diagnostics Incorporated's Q2 2026 Earnings (NYSE:DGX)September 28, 2024 | americanbankingnews.comQuest Diagnostics Incorporated (NYSE:DGX) to Post Q2 2025 Earnings of $2.51 Per Share, Zacks Research ForecastsSeptember 27, 2024 | americanbankingnews.comHow Is Labcorp Holdings’ Stock Performance Compared to Other Healthcare Stocks?September 26, 2024 | msn.comSee More Headlines DGX Stock Analysis - Frequently Asked Questions How have DGX shares performed this year? Quest Diagnostics' stock was trading at $137.88 at the beginning of 2024. Since then, DGX shares have increased by 9.4% and is now trading at $150.79. View the best growth stocks for 2024 here. How were Quest Diagnostics' earnings last quarter? Quest Diagnostics Incorporated (NYSE:DGX) posted its quarterly earnings data on Tuesday, July, 23rd. The medical research company reported $2.35 earnings per share for the quarter, topping the consensus estimate of $2.31 by $0.04. The firm's revenue was up 2.5% compared to the same quarter last year. Read the conference call transcript. How will Quest Diagnostics' stock buyback program work? Quest Diagnostics' Board of Directors approved a share buyback plan on Thursday, February 2nd 2023, which allows the company to buy back $1,000,000,000 in shares, according to EventVestor. This means that the company could repurchase up to 6% of its stock through open market purchases. Stock buyback plans are usually a sign that the company's board of directors believes its shares are undervalued. Does Quest Diagnostics have any subsidiaries? Quest Diagnostics subsidiaries include MACL, Blueprint Genetics, PhenoPath Laboratories, ReproSource, California Laboratory Associates, Cleveland HeartLab, Cape Cod Healthcare - Business, and more. Who are Quest Diagnostics' major shareholders? Top institutional shareholders of Quest Diagnostics include Handelsbanken Fonder AB (0.03%), Czech National Bank (0.02%), Czech National Bank (0.02%) and Massmutual Trust Co. FSB ADV (0.02%). Insiders that own company stock include Stephen H Rusckowski, Catherine T Doherty, Michael E Prevoznik, Michael J Deppe, Timothy M Ring, Vicky B Gregg, Karthik Kuppusamy and Mark E Delaney. View institutional ownership trends. How do I buy shares of Quest Diagnostics? Shares of DGX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Quest Diagnostics own? Based on aggregate information from My MarketBeat watchlists, some other companies that Quest Diagnostics investors own include Xtrackers California Municipal Bond ETF (CA), BlackRock (BLK), Johnson & Johnson (JNJ), Micron Technology (MU), Gilead Sciences (GILD), Pfizer (PFE) and Abbott Laboratories (ABT). Company Calendar Ex-Dividend for 7/22 Dividend7/08/2024Dividend Payable7/22/2024Last Earnings7/23/2024Ex-Dividend for 10/21 Dividend10/04/2024Today10/07/2024Dividend Payable10/21/2024Next Earnings (Confirmed)10/22/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Medical laboratories Sub-IndustryHealth Care Services Current SymbolNYSE:DGX CUSIP74834L10 CIK1022079 Webwww.questdiagnostics.com Phone(973) 520-2700Fax201-462-4169Employees48,000Year Founded1967Price Target and Rating Average Stock Price Target$154.33 High Stock Price Target$165.00 Low Stock Price Target$135.00 Potential Upside/Downside+2.3%Consensus RatingHold Rating Score (0-4)2.31 Research Coverage13 Analysts Profitability EPS (Most Recent Fiscal Year)$7.43 Trailing P/E Ratio20.29 Forward P/E Ratio16.96 P/E Growth2.8Net Income$854 million Net Margins8.99% Pretax Margin11.94% Return on Equity15.35% Return on Assets7.19% Debt Debt-to-Equity Ratio0.57 Current Ratio1.00 Quick Ratio0.91 Sales & Book Value Annual Sales$9.35 billion Price / Sales1.79 Cash Flow$12.48 per share Price / Cash Flow12.08 Book Value$56.41 per share Price / Book2.67Miscellaneous Outstanding Shares111,092,000Free Float110,214,000Market Cap$16.75 billion OptionableOptionable Beta0.89 Social Links This page (NYSE:DGX) was last updated on 10/7/2024 by MarketBeat.com Staff From Our PartnersWar on Elon Escalates… Elon Musk, the guy slated to become the world’s first trillionaire by 2027, has publicly called for the adopti...Porter & Company | SponsoredStrikes and Economic Unrest: Are You Prepared for What’s Coming?The rapid advancement of artificial intelligence and automation is reshaping industries and posing threats to ...InvestorPlace | SponsoredBuffett Dumps $982 Million in BofA Stock—What Does He Know?Buffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track reco...Genesis Gold Group | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredNew President Kamala warningFinancial nightmare coming after election In 2018, one independent research predicted Kamala Harris was on ...Stansberry Research | SponsoredWhat Is the $7,882 Stimulus Payment 2024?Biden’s government just announced a new government "stimulus program"... And it could hand you a payment fo...Angel Publishing | SponsoredKamala’s Dirty Election Move… RevealedAccording to former advisor to the CIA, the Pentagon and the White House Jim Rickards… Kamala and her puppe...Paradigm Press | Sponsored320 hedge funds just sold this stock320 hedge funds just sold this stock A strange force has seized control of Wall Street. Hedge funds are alr...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist My Default Watchlist Adding Quest Diagnostics Incorporated You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Share Quest Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.